.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
McKinsey
Daiichi Sankyo
Novartis
Federal Trade Commission
Fish and Richardson
Covington
Dow
Baxter

Generated: November 17, 2017

DrugPatentWatch Database Preview

SECONAL SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Seconal Sodium, and when can generic versions of Seconal Sodium launch?

Seconal Sodium is a drug marketed by Valeant Pharms North and Lilly and is included in three NDAs.

The generic ingredient in SECONAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the secobarbital sodium profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms North
SECONAL SODIUM
secobarbital sodium
CAPSULE;ORAL086101-001Oct 3, 1983RXNoYes► Subscribe► Subscribe► Subscribe
Lilly
SECONAL SODIUM
secobarbital sodium
INJECTABLE;INJECTION007392-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
SECONAL SODIUM
secobarbital sodium
SUPPOSITORY;RECTAL086530-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
SECONAL SODIUM
secobarbital sodium
CAPSULE;ORAL086101-002Oct 3, 1983RXNoYes► Subscribe► Subscribe► Subscribe
Lilly
SECONAL SODIUM
secobarbital sodium
SUPPOSITORY;RECTAL086530-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
SECONAL SODIUM
secobarbital sodium
SUPPOSITORY;RECTAL086530-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
SECONAL SODIUM
secobarbital sodium
SUPPOSITORY;RECTAL086530-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Johnson and Johnson
Farmers Insurance
Covington
QuintilesIMS
Dow
Novartis
Moodys
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot